• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

250.33 +0.87 (+0.35%)
Official Closing Price Updated: 4:10 PM EDT, Aug 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,647,059
Open 249.49
Bid (Size) 249.00 (100)
Ask (Size) 251.12 (200)
Prev. Close 249.46
Today's Range 248.31 - 251.49
52wk Range 190.75 - 267.47
Shares Outstanding N/A
Dividend Yield 2.76%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year ↗
August 16, 2026
AbbVie has another blockbuster business emerging. 
Via The Motley Fool
News headline image
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More ↗
August 14, 2026
The drugmaker should significantly mitigate its most important risk as it develops new products. 
Via The Motley Fool

Performance

YTD
+9.2%
+9.2%
1 Month
-1.6%
-1.6%
3 Month
+19.5%
+19.5%
6 Month
+7.5%
+7.5%
1 Year
+21.2%
+21.2%

More News

Read More
News headline image
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? ↗
August 14, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
August 12, 2026
From USA News Group
Via GlobeNewswire
News headline image
2 Reasons to Like ABBV and 1 to Stay Skeptical
August 12, 2026
Via StockStory
Topics Stocks Supply Chain
News headline image
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? ↗
August 11, 2026
Via The Motley Fool
News headline image
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026? ↗
August 11, 2026
Via The Motley Fool
Topics Stocks
News headline image
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry? ↗
August 11, 2026
Via The Motley Fool
News headline image
Is AbbVie Stock a Buy After Posting Strong Q2 Earnings? ↗
August 10, 2026
Via The Motley Fool
News headline image
Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026? ↗
August 08, 2026
Via The Motley Fool
Topics ETFs Economy
News headline image
MarketBeat Week in Review – 08/03 - 08/07 ↗
August 08, 2026
Via MarketBeat
Topics Economy Intellectual Property
News headline image
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026? ↗
August 07, 2026
Via The Motley Fool
News headline image
Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire? ↗
August 07, 2026
Via The Motley Fool
News headline image
The 5 Most Interesting Analyst Questions From AbbVie’s Q2 Earnings Call
August 07, 2026
Via StockStory
Topics Earnings
News headline image
3 Cash-Producing Stocks for Long-Term Investors
August 06, 2026
Via StockStory
Topics Energy
News headline image
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now ↗
August 05, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
August 04, 2026
From American News Group
Via GlobeNewswire
News headline image
AbbVie (ABBV) Q2 2026 Earnings Call Transcript ↗
August 03, 2026
Via The Motley Fool
Topics Earnings Economy
News headline image
The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure ↗
August 03, 2026
Via MarketBeat
Topics Artificial Intelligence ETFs Stocks
News headline image
AbbVie Quietly Solved Its Biggest Problem—Now What? ↗
August 02, 2026
Via MarketBeat
Topics Intellectual Property
News headline image
ABBV Q2 Deep Dive: Immunology and Neuroscience Expansion Shape Outlook Amid Guidance Reset
August 01, 2026
Via StockStory
News headline image
Why AbbVie Stock Slumped Today ↗
July 31, 2026
Via The Motley Fool
Topics Earnings
News headline image
Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today ↗
July 31, 2026
Via Benzinga
News headline image
AbbVie Q2 Earnings Call Highlights ↗
July 31, 2026
Via MarketBeat
Topics ETFs Earnings
News headline image
AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat ↗
July 31, 2026
Via Benzinga

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 250.33
When was AbbVie last traded?
The last trade of AbbVie was at 08/17/26 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap